MicroRNA-449a inhibits cell growth in lung cancer and regulates long noncoding RNA nuclear enriched abundant...

Area of Science:

• Oncology
• Molecular Biology
• Gene Regulation

Background:

• Lung cancer is a leading cause of cancer-related mortality, necessitating novel therapeutic strategies.
• MicroRNAs (miRNAs) and long noncoding RNAs (lncRNAs) play critical roles in cancer development, acting as oncogenes or tumor suppressors.
• The specific roles of miR-449a and its interaction with NEAT1 in lung cancer require further elucidation.

Purpose of the Study:

• To investigate the function of miR-449a in lung carcinoma cell lines (NL9980 and L9981).
• To determine the relationship between miR-449a and the lncRNA NEAT1 in lung cancer.
• To assess the impact of miR-449a on lung cancer cell proliferation, apoptosis, and cell cycle progression.

Main Methods:

• Quantitative reverse transcription-polymerase chain reaction (RT-PCR) was used to profile miR-449a expression.
• Overexpression of miR-449a was performed in L9981 cells to analyze effects on proliferation, apoptosis, and cell cycle.
• In silico prediction and experimental assays (inhibitor and mimics) were employed to study the miR-449a and NEAT1 regulatory relationship.

Main Results:

• miR-449a expression was found to be significantly lower in L9981 lung cancer cells compared to NL9980 cells.
• Overexpression of miR-449a in L9981 cells suppressed cell growth and induced apoptosis.
• miR-449a overexpression led to cell cycle arrest in the G1/G0 phase and reduced S and G2/M phases.
• NEAT1 expression was inversely regulated by miR-449a; it increased with miR-449a inhibition and decreased with miR-449a mimics.

Conclusions:

• miR-449a functions as a tumor suppressor in lung cancer.
• miR-449a influences the expression of NEAT1 in lung cancer cells, suggesting a regulatory interaction.
• These findings highlight miR-449a as a potential therapeutic target for lung cancer treatment.